Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Δ9-tetrahydrocannabinol in C57BL/6J mice

Psychopharmacology

Volumn 198, Issue 4, 2008, Pages 487-495

  McMahon, Lance R ^a   Ginsburg, Brett C ^a   Lamb, R J ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

9 THC; Antagonist; Cannabinoid; Drug discrimination; Efficacy; Mouse; Rimonabant; SR 141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALCOHOL; COCAINE; DRONABINOL; KETAMINE; METHANANDAMIDE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; FOOD QUALITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SATISFACTION; STIMULUS RESPONSE; TRAINING;

ANIMALS; ARACHIDONIC ACIDS; BENZOXAZINES; CANNABINOIDS; CYCLOHEXANOLS; DATA INTERPRETATION, STATISTICAL; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HALLUCINOGENS; MALE; MICE; MICE, INBRED C57BL; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT SCHEDULE; TETRAHYDROCANNABINOL;

EID: 44449118561     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0900-2     Document Type: Article

References (35)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A (1994) (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37:1889-1893
2. 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci Biobehav Rev 16:55-62
3. 1 knockout and wild-type mice. J Pharmacol Exp Ther 309:86-91
4. A-ergic ligands. Psychopharmacology 153:67-84
5. 9-THC in a drug-discrimination procedure. Exp Clin Psychopharmacol 5:195-202
6. Chait LD, Evans SM, Grant KA, Kamien JB, Johanson CE, Schuster CR (1988) Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology 94:206-212
7. Childers SR (2006) Activation of G-proteins in brain by endogenous and exogenous cannabinoids. AAPS J 8:E112-E117
8. 9-tetrahydrocannabinol. J Pharmacol Exp Ther 263:1118-1126
9. De Vry J, Jentzsch KR, Kuhl E, Eckel G (2004) Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav Pharmacol 15:1-12
10. Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796
11. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313:352-358
12. 9- tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys. J Pharmacol Exp Ther 262:479-486
13. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202
14. 9-THC), and other drugs. Psychopharmacologia 40:1-16
15. 9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN. Arch Int Pharmacodyn Ther 228:68-72
16. 9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology 140:519-522
17. 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology 156:369-380
18. Järbe TU, Liu Q, Makriyannis A (2006) Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats. Psychopharmacology 184:36-45
19. Kenakin T (1997) Pharmacologic analysis of drug-receptor interaction. Lippincott-Raven, Philadelphia, PA
20. Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471-478
21. 9-tetrahydrocannabinol. J Pharmacol Exp Ther 319:1211-1218
22. 9-tetrahydrocannabinol. Psychopharmacology 188:306-314
23. McMahon LR, Koek W (2007) Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. Eur J Pharmacol, in press
24. Morozov A, Kellendonk C, Simpson E, Tronche F (2003) Using conditional mutagenesis to study the brain. Biol Psychiatry 54:1125-1133
25. National Research Council (2003) Guidelines for the care and use of mammals in neuroscience and behavioral research. National Academies Press, Washington, DC
26. Petitet F, Jeantaud B, Bertrand P, Imperato A (1999) Cannabinoid penetration into mouse brain as determined by ex vivo binding. Eur J Pharmacol 374:417-421
27. Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br J Pharmacol 132:631-640
28. Shelton KL (2004) Substitution profiles of N-methyl-D-aspartate antagonists in ethanol-discriminating inbred mice. Alcohol 34:165-175
29. Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR (2007) The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. J Pharmacol Exp Ther 321:370-380
30. Tallarida RJ (2000) Drug synergism and dose-effect data analysis. CRC, Boca Raton, FL
31. Wiley JL (1999) Cannabis: discrimination of "internal bliss"? Pharmacol Biochem Behav 64:257-260
32. Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471:185-193
33. 9- tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend 40:81-86
34. Wiley JL, Golden KM, Ryan WJ, Balster RL, Razdan RK, Martin BR (1997) Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Pharmacol Biochem Behav 58:1139-1143
35. Wiley JL, Ryan WJ, Razdan RK, Martin BR (1998) Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. Eur J Pharmacol 355:113-118